Furthermore, we validated several miRNAs nodes that have been dysregulated during gemcitabine resistance, and subsequently confirmed the role of miR-30a in pancreatic cancer cell sensitization to chemotherapy, mainly through SNAI1/IRS1/ERK/AKT pathway. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.